Clonidine
Reason category: cGMP deviations
FDA recall number D-0473-2026
Blood pressure
Clonidine 0.1 mg tablet
Public data on clonidine from CMS and FDA: what pharmacies have paid for it, how many generic applications FDA has approved, and whether it appears in FDA's shortage or recall records.
$0.0233
NADAC per ea (2026-11)
approximate acquisition cost, not a retail price
-23%
change over five years
peak $0.0336 in 2019-05
33
approved generic applications (ANDAs) on record for Clonidine Hydrochloride
22 with a product still marketed · first 1986
Not listed
in FDA's current shortage list
no matching FDA shortage entries
NADAC per unit, monthly
CLONIDINE HCL 0.1 MG TABLETShow as table
| Month | NADAC per unit ($) |
|---|---|
| 2013-11 | 0.02805 |
| 2014-02 | 0.02981 |
| 2014-05 | 0.02749 |
| 2014-08 | 0.02830 |
| 2014-11 | 0.02789 |
| 2015-02 | 0.02865 |
| 2015-05 | 0.02966 |
| 2015-08 | 0.02683 |
| 2015-11 | 0.02549 |
| 2016-02 | 0.02907 |
| 2016-05 | 0.02927 |
| 2016-08 | 0.02758 |
| 2016-11 | 0.02659 |
| 2017-02 | 0.02414 |
| 2017-05 | 0.02488 |
| 2017-08 | 0.02464 |
| 2017-11 | 0.02379 |
| 2018-02 | 0.02362 |
| 2018-05 | 0.02206 |
| 2018-08 | 0.02443 |
| 2018-11 | 0.02161 |
| 2019-02 | 0.02976 |
| 2019-05 | 0.03365 |
| 2019-08 | 0.03211 |
| 2019-11 | 0.03083 |
| 2020-02 | 0.03274 |
| 2020-05 | 0.02976 |
| 2020-08 | 0.02846 |
| 2020-11 | 0.02869 |
| 2021-02 | 0.02965 |
| 2021-05 | 0.02975 |
| 2021-08 | 0.03044 |
| 2021-11 | 0.03019 |
| 2022-02 | 0.02892 |
| 2022-05 | 0.02874 |
| 2022-08 | 0.02791 |
| 2022-11 | 0.02808 |
| 2023-02 | 0.02571 |
| 2023-05 | 0.02690 |
| 2023-08 | 0.02793 |
| 2023-11 | 0.02738 |
| 2024-02 | 0.02629 |
| 2024-05 | 0.02211 |
| 2024-08 | 0.02442 |
| 2024-11 | 0.02304 |
| 2025-02 | 0.02403 |
| 2025-05 | 0.02558 |
| 2025-08 | 0.02547 |
| 2025-11 | 0.02491 |
| 2026-02 | 0.02521 |
| 2026-05 | 0.02473 |
| 2026-08 | 0.02470 |
| 2026-11 | 0.02330 |
Source: CMS NADAC weekly files, generic rows, monthly median of weekly averages · data as of 2026-11. Figures can change and may contain errors in the source data. Check the original source before relying on them.
Recall records mentioning clonidine
openFDA enforcement records, by year reported.
| 2026 | 3 |
| 2025 | 1 |
| 2023 | 1 |
| 2022 | 6 |
| 2021 | 2 |
| 2020 | 6 |
| 2019 | 21 |
| 2018 | 2 |
| 2016 | 5 |
| 2015 | 37 |
94 records since 2012. A record is one product or lot, not one recall event. Combination products that contain clonidine are included.
What these numbers mean
NADAC is what retail pharmacies pay on average to buy the drug, published by CMS. It does not include rebates and is not what you pay at the counter. ANDA counts include all strengths and forms and applications whose products are now discontinued.
Most recent recall records
Clonidine
Reason category: cGMP deviations
FDA recall number D-0474-2026
Clonidine
Reason category: cGMP deviations
FDA recall number D-0472-2026
Clonidine product
Reason category: Sterility / contamination
FDA recall number D-0113-2026
Clonidine product
Reason category: cGMP deviations
FDA recall number D-0784-2023
Not health advice. GxRadar is for general information only. Nothing here is medical, pharmacy, legal or financial advice. Do not start, stop or change any medicine based on this site. Talk to your pharmacist or prescriber about your own situation.
Articles that mention clonidine
2 GxRadar articles cite or discuss this drug.
Equivalence & alternatives · Explainer · 6 min
The 505(b)(2) pathway, between brand and generic
How FDA's hybrid new drug application works, how it differs from a full NDA and a generic ANDA, and what three years of approval data show about who uses it.
Price histories · Data story · 5 min
The cheapest pills in GxRadar's 47-drug price basket
Seven of the 47 generics we track cost pharmacies under 2 cents a unit in October 2026, led by amlodipine at 1.02 cents. Which drugs sit at the floor, how long they have been there, and what the ranking does not show.